Uniform Formulary Beneficiary Advisory Panel; Notice of Federal Advisory Committee

Issuing agencies

Abstract

The DoD (referred to herein as "the Department", "Department of War" or "DoW") is publishing this notice to announce that the following Federal Advisory Committee meeting of the Uniform Formulary Beneficiary Advisory Panel (UFBAP) will take place.

Full Text

<html>
<head>
<title>Federal Register, Volume 91 Issue 171 (Friday, September 4, 2026)</title>
</head>
<body><pre>
[Federal Register Volume 91, Number 171 (Friday, September 4, 2026)]
[Notices]
[Pages 56871-56872]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2026-18114]


-----------------------------------------------------------------------

DEPARTMENT OF DEFENSE

Office of the Secretary


Uniform Formulary Beneficiary Advisory Panel; Notice of Federal 
Advisory Committee

AGENCY:  Under Secretary of Defense for Personnel and Readiness 
(USD(P&R)), Department of Defense (DoD).

ACTION: Notice of Federal Advisory Committee meeting.

-----------------------------------------------------------------------

SUMMARY:  The DoD (referred to herein as ``the Department'', 
``Department of War'' or ``DoW'') is publishing this notice to announce 
that the following Federal Advisory Committee meeting of the Uniform 
Formulary Beneficiary Advisory Panel (UFBAP) will take place.

DATES:  Open to the public.
    <bullet> Wednesday, September 23rd, 10:00 a.m.-1:00 p.m. (Eastern 
Standard Time).

ADDRESSES: The meeting will be held telephonically or via conference 
call. The phone number for remote access is: 1-667-892-3500 or 1-667-
892-3600.
    Participant Code: 328199967.
    These numbers and the dial-in instructions will also be posted on 
the UFBAP website at: <a href="https://www.health.mil/Military-Health-Topics/Access-Cost-Quality-and-Safety/Pharmacy-Operations/BAP">https://www.health.mil/Military-Health-Topics/Access-Cost-Quality-and-Safety/Pharmacy-Operations/BAP</a>.

FOR FURTHER INFORMATION CONTACT:  Alternate Designated Federal Official 
(ADFO) Captain Phung Thien Nguyen, USPHS, 703-681-2890 (voice), 
<a href="/cdn-cgi/l/email-protection#f6929e97d8989584d89cdbc0d89b948ed89497868493878393858285b69e93979a829ed89b9f9a"><span class="__cf_email__" data-cfemail="e0848881ce8e8392ce8acdd6ce8d8298ce8281909285919585939493a08885818c9488ce8d898c">[email&#160;protected]</span></a> (email). Mailing address is 7700 
Arlington Boulevard, Suite 5101, Falls Church, VA 22042-5101. Website: 
<a href="https://www.health.mil/Military-Health-Topics/Access-Cost-Quality-and-Safety/Pharmacy-Operations/BAP">https://www.health.mil/Military-Health-Topics/Access-Cost-Quality-and-Safety/Pharmacy-Operations/BAP</a>. The most up-to-date changes to the 
meeting agenda can be found on the website.

SUPPLEMENTARY INFORMATION:  This meeting is held under the provisions 
of chapter 10 of title 5, United States Code

[[Page 56872]]

(U.S.C.) (commonly known as the Federal Advisory Committee Act or FACA) 
and 41 Code of Federal Regulations (CFR) 102-3.140 and 102-3.150.
    Purpose of the Meeting: The UFBAP will review and comment on 
recommendations made by the DoW Pharmacy and Therapeutics Committee to 
the Director, Defense Health Agency regarding the Uniform Formulary.

Agenda

1. 10:00 a.m.-10:10 a.m. Sign In for UFBAP members
2. 10:10 a.m.-10:40 a.m. Welcome and Opening Remarks
    a. Welcome, Opening Remarks, and Introduction of UFBAP Members by 
CAPT Phung Thien Nguyen, ADFO, UFBAP
    b. Public Written Comments by CAPT Phung Thien Nguyen, ADFO, UFBAP
    c. Opening Remarks by Dr. Pamela Schweitzer, UFBAP Chair
    d. Introductory Remarks by Dr. Edward Vonberg, Chief, Formulary 
Management Branch
3. 10:40 a.m.-11:45 a.m. Scheduled Therapeutic Class Reviews
4. 11:45 a.m.-12:30 p.m. Newly Approved Drugs Review
5. 12:30 p.m.-12:45 p.m. Pertinent Utilization Management Issues
6. 12:45 p.m.-1:00 p.m. Closing remarks
    a. Closing Remarks by UFBAP Chair
    b. Closing Remarks by ADFO, UFBAP
    Meeting Accessibility: Pursuant to section 1009(a)(1) of title 5, 
U.S.C. and 41 CFR 102-3.140 through 102-3.165, and subject to the 
availability of phone lines, the meeting is open to the public.
    Written Statements: Pursuant to 41 CFR 102-3.105(j) and 102-
3.140(c), and section 1009(a)(3) of title 5, U.S.C., interested persons 
or organizations may submit written statements to the UFBAP about its 
mission and/or the agenda to be addressed in the public meetings. 
Written statements should be submitted to the UFBAP's ADFO. The ADFO's 
contact information can be found in the FOR FURTHER INFORMATION CONTACT 
section of this notice. Written comments or statements must be received 
by the UFBAP's ADFO at least five (5) calendar days prior to a meeting 
so they may be made available to the UFBAP for its consideration prior 
to a meeting. Written comments received are releasable to the public. 
The ADFO will review all submitted written statements and provide 
copies to UFBAP.

    Dated: September 1, 2026.
Stephanie J. Bost,
Alternate OSD Federal Register Liaison Officer, Department of Defense.
[FR Doc. 2026-18114 Filed 9-3-26; 8:45 am]
BILLING CODE 6001-FR-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>